Exact Mass: 320.0176

Exact Mass Matches: 320.0176

Found 43 metabolites which its exact mass value is equals to given mass value 320.0176, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

lorazepam

lorazepam

C15H10Cl2N2O2 (320.0119)


D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D006993 - Hypnotics and Sedatives D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014151 - Anti-Anxiety Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents N - Nervous system > N05 - Psycholeptics > N05B - Anxiolytics > N05BA - Benzodiazepine derivatives C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic > C1012 - Benzodiazepine D018377 - Neurotransmitter Agents > D018682 - GABA Agents > D018757 - GABA Modulators D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent D002491 - Central Nervous System Agents > D000927 - Anticonvulsants C78272 - Agent Affecting Nervous System > C267 - Antiemetic Agent D005765 - Gastrointestinal Agents > D000932 - Antiemetics CONFIDENCE standard compound; INTERNAL_ID 1512 CONFIDENCE standard compound; INTERNAL_ID 8600 CONFIDENCE standard compound; EAWAG_UCHEM_ID 3138

   

Lorazepam

7-chloro-5-(2-chlorophenyl)-3-hydroxy-2,3-dihydro-1H-1,4-benzodiazepin-2-one

C15H10Cl2N2O2 (320.0119)


Lorazepam is only found in individuals that have used or taken this drug. It is a benzodiazepine used as an anti-anxiety agent with few side effects. It also has hypnotic, anticonvulsant, and considerable sedative properties and has been proposed as a preanesthetic agent. [PubChem]Lorazepam binds to an allosteric site on GABA-A receptors, which are pentameric ionotropic receptors in the CNS. Binding potentiates the effects of the inhibitory neurotransmitter GABA, which upon binding opens the chloride channel in the receptor, allowing chloride influx and causing hyperpolerization of the neuron. D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D006993 - Hypnotics and Sedatives D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014151 - Anti-Anxiety Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents N - Nervous system > N05 - Psycholeptics > N05B - Anxiolytics > N05BA - Benzodiazepine derivatives C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic > C1012 - Benzodiazepine D018377 - Neurotransmitter Agents > D018682 - GABA Agents > D018757 - GABA Modulators D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent D002491 - Central Nervous System Agents > D000927 - Anticonvulsants C78272 - Agent Affecting Nervous System > C267 - Antiemetic Agent D005765 - Gastrointestinal Agents > D000932 - Antiemetics

   

Luteic acid

Luteic acid

C14H8O9 (320.0168)


   

Lonidamine

1-[(2,4-dichlorophenyl)methyl]-1H-indazole-3-carboxylic acid

C15H10Cl2N2O2 (320.0119)


D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents D012102 - Reproductive Control Agents > D003270 - Contraceptive Agents C274 - Antineoplastic Agent > C798 - Radiosensitizing Agent D009676 - Noxae > D000988 - Antispermatogenic Agents D011838 - Radiation-Sensitizing Agents C1744 - Multidrug Resistance Modulator D000970 - Antineoplastic Agents Lonidamine (AF-1890) is a hexokinase and mitochondrial pyruvate carrier inhibitor (Ki: 2.5 μM). Lonidamine also inhibits aerobic glycolysis in cancer cells. Lonidamine can be used in the research of mitochondrial metabolism and inflammation, such as pulmonary fibrosis[1][2][3].

   

8-Chloro-3,4,5,7-tetrahydroxyisoflavone

8-Chloro-3,4,5,7-tetrahydroxyisoflavone

C15H9ClO6 (320.0088)


   

Luteic acid

Luteic acid

C14H8O9 (320.0168)


   

UNII-LAY5YR2K7G

UNII-LAY5YR2K7G

C15H9ClO6 (320.0088)


   

3-Chloro-1, 2, 4, 5-tetrahydroxy-7-methylanthraquinone

3-Chloro-1, 2, 4, 5-tetrahydroxy-7-methylanthraquinone

C15H9ClO6 (320.0088)


   

Valsarin

Valsarin

C15H9ClO6 (320.0088)


   

5-Chloro-w-hydroxyemodin

5-Chloro-w-hydroxyemodin

C15H9ClO6 (320.0088)


   

rel-(1R,5S)-3-(1-acetoxybutyl)-4-bromo-5-methyl-5-methoxy-2(5H)-furanone

rel-(1R,5S)-3-(1-acetoxybutyl)-4-bromo-5-methyl-5-methoxy-2(5H)-furanone

C12H17BrO5 (320.0259)


   

Ellagic acid hydrate

6,7,13,14-tetrahydroxy-2,9-dioxatetracyclo[6.6.2.0^{4,16}.0^{11,15}]hexadeca-1(15),4(16),5,7,11,13-hexaene-3,10-dione hydrate

C14H8O9 (320.0168)


   

Lonidamine

Lonidamine

C15H10Cl2N2O2 (320.0119)


D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents D012102 - Reproductive Control Agents > D003270 - Contraceptive Agents C274 - Antineoplastic Agent > C798 - Radiosensitizing Agent D009676 - Noxae > D000988 - Antispermatogenic Agents D011838 - Radiation-Sensitizing Agents C1744 - Multidrug Resistance Modulator D000970 - Antineoplastic Agents Lonidamine (AF-1890) is a hexokinase and mitochondrial pyruvate carrier inhibitor (Ki: 2.5 μM). Lonidamine also inhibits aerobic glycolysis in cancer cells. Lonidamine can be used in the research of mitochondrial metabolism and inflammation, such as pulmonary fibrosis[1][2][3].

   

2-chloro-1,3,8-trihydroxy-6-(hydroxymethyl)anthracene-9,10-dione

2-chloro-1,3,8-trihydroxy-6-(hydroxymethyl)anthracene-9,10-dione

C15H9ClO6 (320.0088)


   

2-chloro-1,3,8-trihydroxy-6-(hydroxymethyl)anthracene-9,10-dione_major

2-chloro-1,3,8-trihydroxy-6-(hydroxymethyl)anthracene-9,10-dione_major

C15H9ClO6 (320.0088)


   

7-Chlorocitreosein

2-Chloro-1,3,8-trihydroxy-6-(hydroxymethyl)-9,10-anthraquinone

C15H9ClO6 (320.0088)


   

1-(5-BROMO-1H-INDOL-3-YL)-2-(PYRROLIDIN-1-YL)ETHANE-1,2-DIONE

1-(5-BROMO-1H-INDOL-3-YL)-2-(PYRROLIDIN-1-YL)ETHANE-1,2-DIONE

C14H13BrN2O2 (320.016)


   

(2-(Benzyloxy)-3-bromo-5-methylphenyl)boronic acid

(2-(Benzyloxy)-3-bromo-5-methylphenyl)boronic acid

C14H14BBrO3 (320.0219)


   

A-3 hydrochloride

A-3 hydrochloride

C12H14Cl2N2O2S (320.0153)


   

4-iodo-1-methoxy-2-pentoxybenzene

4-iodo-1-methoxy-2-pentoxybenzene

C12H17IO2 (320.0273)


   

2-(5-bromo-2- pyridylazo)-5-dimethylaminophenol

2-(5-bromo-2- pyridylazo)-5-dimethylaminophenol

C13H13BrN4O (320.0273)


   

4-Chloro-1-((3-(trifluoromethyl)phenoxy)Methyl)-1H-pyrazole-3-carboxylic acid

4-Chloro-1-((3-(trifluoromethyl)phenoxy)Methyl)-1H-pyrazole-3-carboxylic acid

C12H8ClF3N2O3 (320.0176)


   

5-(2-chlorophenyl)-7-ethyl-1H-thieno[2,3-e][1,4]diazepine-2(3H)-thione

5-(2-chlorophenyl)-7-ethyl-1H-thieno[2,3-e][1,4]diazepine-2(3H)-thione

C15H13ClN2S2 (320.0209)


   

7-chloro-5-(2-chlorophenyl)-1,3-dihydro-2H-benzo-1,4-diazepin-2-one 4-oxide

7-chloro-5-(2-chlorophenyl)-1,3-dihydro-2H-benzo-1,4-diazepin-2-one 4-oxide

C15H10Cl2N2O2 (320.0119)


   

2-[6-chloro-2-(4-chlorophenyl)imidazo[1,2-a]pyridin-3-yl]acetic acid

2-[6-chloro-2-(4-chlorophenyl)imidazo[1,2-a]pyridin-3-yl]acetic acid

C15H10Cl2N2O2 (320.0119)


   

9-Bromo-9-phenylfluorene

9-Bromo-9-phenylfluorene

C19H13Br (320.0201)


   

CalciuM Saccharate

CalciuM Saccharate

C6H16CaO12 (320.0268)


   

5-Bromo-N-(4-methoxybenzyl)picolinamide

5-Bromo-N-(4-methoxybenzyl)picolinamide

C14H13BrN2O2 (320.016)


   

1-BOC-3-BROMO-5-CYANOINDOLE

1-BOC-3-BROMO-5-CYANOINDOLE

C14H13BrN2O2 (320.016)


   

2,6-Dichloro-9-(β-D-ribofuranosyl)-9H-purine

2,6-Dichloro-9-(β-D-ribofuranosyl)-9H-purine

C10H10Cl2N4O4 (320.0079)


   

1H-Indazole-3-carboxylic acid, 1-(3,4-dichlorobenzyl)-

1H-Indazole-3-carboxylic acid, 1-(3,4-dichlorobenzyl)-

C15H10Cl2N2O2 (320.0119)


   

3-[(4-Bromophenoxy)methyl]benzohydrazide

3-[(4-Bromophenoxy)methyl]benzohydrazide

C14H13BrN2O2 (320.016)


   

2-Chloro-1,3,8-trihydroxy-6-(hydroxymethyl)anthraquinone

2-Chloro-1,3,8-trihydroxy-6-(hydroxymethyl)anthraquinone

C15H9ClO6 (320.0088)


   

4-fluoro-N-(7-methyl-4-oxo-2-thieno[3,2-d][1,3]thiazinyl)benzamide

4-fluoro-N-(7-methyl-4-oxo-2-thieno[3,2-d][1,3]thiazinyl)benzamide

C14H9FN2O2S2 (320.0089)


   

2-(2-bromophenoxy)-N-(2-pyridinylmethyl)acetamide

2-(2-bromophenoxy)-N-(2-pyridinylmethyl)acetamide

C14H13BrN2O2 (320.016)


   

(1s)-1-[(5r)-4-bromo-5-methoxy-5-methyl-2-oxofuran-3-yl]butyl acetate

(1s)-1-[(5r)-4-bromo-5-methoxy-5-methyl-2-oxofuran-3-yl]butyl acetate

C12H17BrO5 (320.0259)


   

1-chloro-2,4,5-trihydroxy-7-(hydroxymethyl)anthracene-9,10-dione

1-chloro-2,4,5-trihydroxy-7-(hydroxymethyl)anthracene-9,10-dione

C15H9ClO6 (320.0088)


   

(1r)-1-[(5r)-4-bromo-5-methoxy-5-methyl-2-oxofuran-3-yl]butyl acetate

(1r)-1-[(5r)-4-bromo-5-methoxy-5-methyl-2-oxofuran-3-yl]butyl acetate

C12H17BrO5 (320.0259)


   

(3r)-3-[(2r)-3,3-dichloro-2-hydroxypropyl]-8-hydroxy-6-methoxy-3,4-dihydro-2-benzopyran-1-one

(3r)-3-[(2r)-3,3-dichloro-2-hydroxypropyl]-8-hydroxy-6-methoxy-3,4-dihydro-2-benzopyran-1-one

C13H14Cl2O5 (320.0218)


   

8-chloro-3-(3,4-dihydroxyphenyl)-5,7-dihydroxychromen-4-one

8-chloro-3-(3,4-dihydroxyphenyl)-5,7-dihydroxychromen-4-one

C15H9ClO6 (320.0088)


   

bonton

bonton

C15H10Cl2N2O2 (320.0119)


   

1-(4-bromo-5-methoxy-5-methyl-2-oxofuran-3-yl)butyl acetate

1-(4-bromo-5-methoxy-5-methyl-2-oxofuran-3-yl)butyl acetate

C12H17BrO5 (320.0259)


   

(1r)-1-[(5s)-4-bromo-5-methoxy-5-methyl-2-oxofuran-3-yl]butyl acetate

(1r)-1-[(5s)-4-bromo-5-methoxy-5-methyl-2-oxofuran-3-yl]butyl acetate

C12H17BrO5 (320.0259)